AUTORIZZAZIONE ALL’ESECUZIONE DEL PROGETTO DAL TITOLO “UNDERSTANDING TUMOR AND IMMUNE DYNAMICS AND PREDICTING POOR OUTCOME TO INTRAVESCICAL THERAPIES (BCG) IN PATIENTS WITH NON-MUSCLE-INVASIVE BLADDER CANCER (NMIBC) THAT HAD PROGRESSED IN LOCALLY ADVANCE/METASTATIC DISEASE” - PROT. INT N. 170/24 - FINANZIATO DALL’APS ASSOCIAZIONE PALINURO